Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cancer Registry Software Market, by Type
1.4.2 North America Cancer Registry Software Market, by Deployment Type
1.4.3 North America Cancer Registry Software Market, by Component
1.4.4 North America Cancer Registry Software Market, by End User
1.4.5 North America Cancer Registry Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Cancer Registry Software Market by Type
3.1 North America Integrated Cancer Registry Software Market by Country
3.2 North America Standalone Cancer Registry Software Market by Country
Chapter 4. North America Cancer Registry Software Market by Deployment Model
4.1 North America On-premise Cancer Registry Software Market by Country
4.2 North America Cloud-based Cancer Registry Software Market by Country
Chapter 5. North America Cancer Registry Software Market by Component
5.1 North America Commercial Cancer Registry Software Market by Country
5.2 North America Public Cancer Registry Software Market by Country
Chapter 6. North America Cancer Registry Software Market by End User
6.1 North America Government & Third party Market by Country
6.2 North America Research Centers Market by Country
6.3 North America Hospital & Medical Centers Market by Country
6.4 North America Private Payers Market by Country
6.5 North America Pharma biotech & medical device suppliers Market by Country
Chapter 7. North America Cancer Registry Software Market by Country
7.1 USA Cancer Registry Software Market
7.1.1 USA Cancer Registry Software Market by Type
7.1.2 USA Cancer Registry Software Market by Deployment Model
7.1.3 USA Cancer Registry Software Market by Component
7.1.4 USA Cancer Registry Software Market by End User
7.2 Canada Cancer Registry Software Market
7.2.1 Canada Cancer Registry Software Market by Type
7.2.2 Canada Cancer Registry Software Market by Deployment Model
7.2.3 Canada Cancer Registry Software Market by Component
7.2.4 Canada Cancer Registry Software Market by End User
7.3 Mexico Cancer Registry Software Market
7.3.1 Mexico Cancer Registry Software Market by Type
7.3.2 Mexico Cancer Registry Software Market by Deployment Model
7.3.3 Mexico Cancer Registry Software Market by Component
7.3.4 Mexico Cancer Registry Software Market by End User
7.4 Rest of North America Cancer Registry Software Market
7.4.1 Rest of North America Cancer Registry Software Market by Type
7.4.2 Rest of North America Cancer Registry Software Market by Deployment Model
7.4.3 Rest of North America Cancer Registry Software Market by Component
7.4.4 Rest of North America Cancer Registry Software Market by End User
Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.3.4 Recent strategies and developments:
8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
8.5.1 Company Overview
8.6 Onco, Inc.
8.6.1 Company Overview
8.7 C/Net Solutions
8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
8.10.1 Company Overview
Unique Offerings 